HTATSF1: Key Protein in Hepatitis B (G27336)

Target Name: HTATSF1

NCBI ID: G27336

HTATSF1

HTATSF1: Key Protein in Hepatitis B

HTATSF1 (Hepatitis B virus surface antigen 1) is a protein that is present on the surface of the hepatitis B virus (HBV). It is a key protein that is used by the virus to infect and replicate itself in the host cells. HTATSF1 is also an important protein that is used as a marker for the diagnosis and assessment of the severity of hepatitis B.

HTATSF1 is a glycoprotein that consists of four chains. It has a molecular weight of approximately 17 kDa and a pre-fusion structure of five transmembrane domains and one cytoplasmic tail. HTATSF1 is expressed in most tissues and cells of the host, including the liver, where it is present in the cytoplasm and in the cell membrane.

HTATSF1 is involved in the replication of the hepatitis B virus. The virus uses its surface antigens, including HTATSF1, to infect host cells and then replicates its DNA in the cells. This process is essential for the virus's survival and continuation.

HTATSF1 is also involved in the immune response to the hepatitis B virus. It is a key protein that is recognized by the host's immune system and is used as an antigen by the antibodies produced by the immune system. These antibodies are responsible for neutralizing the virus and preventing it from causing further damage to the host.

HTATSF1 is also used as a marker for the assessment of the severity of hepatitis B. The level of HTATSF1 expression in the liver can be used to determine the degree of liver damage caused by the virus. In addition, the level of HTATSF1 expression in the blood can be used to determine the level of the virus's replication in the body and to monitor the effectiveness of antiviral therapy.

HTATSF1 is also a potential drug target for hepatitis B. The virus's replication and immune evasion mechanisms have been the focus of much research in the development of new treatments for hepatitis B. HTATSF1 is an important protein that is involved in both the virus's replication and the immune response to the virus. Therefore, targeting HTATSF1 with small molecules or antibodies may be an effective way to treat hepatitis B.

In conclusion, HTATSF1 is a protein that is involved in the replication and immune response of the hepatitis B virus. Its level is an important marker for the diagnosis and assessment of the severity of hepatitis B and may also be used as a drug target. Further research is needed to fully understand the role of HTATSF1 in the treatment of hepatitis B and to develop effective new treatments for this disease.

Protein Name: HIV-1 Tat Specific Factor 1

Functions: Functions as a general transcription factor playing a role in the process of transcriptional elongation. May mediate the reciprocal stimulatory effect of splicing on transcriptional elongation. In case of infection by HIV-1, it is up-regulated by the HIV-1 proteins NEF and gp120, acts as a cofactor required for the Tat-enhanced transcription of the virus

The "HTATSF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HTATSF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets